Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Agilent Technologies Inc (A) vs Huntington Ingalls Industries Inc (HII) Price & Performance

Agilent Technologies Inc
Huntington Ingalls Industries Inc

Price performance

Price movement over the last 24 hours

Key statistics

Agilent Technologies Inc vs Huntington Ingalls Industries Inc — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while Huntington Ingalls Industries Inc trades at $288.58 (market cap $11.41B). The key difference: Agilent Technologies Inc is far larger — about 3.2× Huntington Ingalls Industries Inc's market cap, and Huntington Ingalls Industries Inc pays the higher dividend (1.91%). Which is the better fit depends on your goals.

AHII
Market Cap
$37.04B$11.41B
Sector
HealthTechnology
52-Week High
$157.20$453.73
52-Week Low
$110.24$247.95
Enterprise Value
$38.59B$14.12B
Dividend Yield
0.78%1.91%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Agilent Technologies Inc

Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.

The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.

Huntington Ingalls Industries Inc

HII trades at $294.10, up 0.89% with a bullish technical signal supported by recent contract wins and strong earnings beats. The company maintains solid fundamentals with a 4.71% net margin and 12.2% ROE, while analyst consensus targets $384.50 representing 31% upside potential. Recent developments include a $418 million Navy contract and expansion in unmanned systems production.

HII presents a compelling investment case with consistent earnings outperformance, robust defense contracts, and attractive valuation metrics. Key risks include defense budget dependencies and execution challenges, but the company's $54 billion backlog and strategic positioning in naval shipbuilding support long-term growth prospects.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Agilent Technologies Inc

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.

Read more on A

About Huntington Ingalls Industries Inc

Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.

Read more on HII